Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soler

Showing results (101-110 of 11,550) with videos related to

Pageof 1,155
Sort By:
Atencion Primaria|October 15, 1995
[Future of general/family medicine in Spain and possible role of the Spanish Society of Family and Community Medicine]M Soler Torroja
Actas Dermo-Sifiliograficas|October 29, 2010
Leishmaniosis sine leishmaniaJ SOLER BURGOS
Neurologia (Barcelona, Spain)|April 1, 1991
[The concept of leukoaraiosis]L Soler Singla
Revista Espanola De Las Enfermedades Del Aparato Digestivo|May 1, 1980
[Capillarosis]J Soler Canto
The Oncologist|February 3, 2004
HER1/EGFR targeting: refining the strategyRomán Pérez-Soler
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
The role of erlotinib (Tarceva, OSI 774) in the treatment of non-small cell lung cancerRoman Perez-Soler
Dental World (London, England)|January 1, 1993
A dentist at the OlympicsD Soler Badia
Clinical Lung Cancer|January 11, 2005
Phase II clinical trial data with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib (OSI-774) in non-small-cell lung cancerRoman Perez-Soler
Physical Review. A, General Physics|March 1, 1988
Coulomb fragmentation of doubly ionized molecular clustersCasero, Sáenz, Soler
Clinical Lung Cancer|January 24, 2007
Rash as a surrogate marker for efficacy of epidermal growth factor receptor inhibitors in lung cancerRoman Perez-Soler
Pageof 1,155

Showing results (101-110 of 11,550) with videos related to

Sort By:
Pageof 1,155
Atencion Primaria|October 15, 1995
[Future of general/family medicine in Spain and possible role of the Spanish Society of Family and Community Medicine]M Soler Torroja
Actas Dermo-Sifiliograficas|October 29, 2010
Leishmaniosis sine leishmaniaJ SOLER BURGOS
Neurologia (Barcelona, Spain)|April 1, 1991
[The concept of leukoaraiosis]L Soler Singla
Revista Espanola De Las Enfermedades Del Aparato Digestivo|May 1, 1980
[Capillarosis]J Soler Canto
The Oncologist|February 3, 2004
HER1/EGFR targeting: refining the strategyRomán Pérez-Soler
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
The role of erlotinib (Tarceva, OSI 774) in the treatment of non-small cell lung cancerRoman Perez-Soler
Dental World (London, England)|January 1, 1993
A dentist at the OlympicsD Soler Badia
Clinical Lung Cancer|January 11, 2005
Phase II clinical trial data with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib (OSI-774) in non-small-cell lung cancerRoman Perez-Soler
Physical Review. A, General Physics|March 1, 1988
Coulomb fragmentation of doubly ionized molecular clustersCasero, Sáenz, Soler
Clinical Lung Cancer|January 24, 2007
Rash as a surrogate marker for efficacy of epidermal growth factor receptor inhibitors in lung cancerRoman Perez-Soler
Pageof 1,155